This study demonstrates that CFHR4 does not play an independent role in AMD disease initiation or progression, and that modulation of FHR-4 is unlikely to be an effective therapeutic strategy for this blinding disease. The gene discussed is CFHR4; the disease is age-related macular degeneration.